The Initial Treatment of Systemic Juvenile Idiopathic Arthritis:An International Collaboration among 10 Registries.
Mary Beth F. Son(Boston Children's Hospital), Timothy Beukelman(University of Alabama at Birmingham), Jens Klotsche(German Rheumatism Research Centre), Kristiina Aalto(University of Helsinki), Kimme L Hyrich(Manchester Royal Infirmary), Bo Magnusson(Karolinska University Hospital), Ciarán M. Duffy, Troels Herlin(Aarhus University Hospital), Yukiko Kimura(Hackensack University Medical Center), Vanessa Mcityre, Lillemor Berntson, Ellen Nordal(University Hospital of North Norway), Jaime Guzmán(University of British Columbia), Seza Özen(Hacettepe University), Petteri Hovi(University of Helsinki), Mia Glerup(Aarhus University Hospital), Betül Sözeri(Ümraniye Eğitim ve Araştırma Hastanesi), Maria Jose Santos, Jonathan Dallas
Unknown
April 1, 2020
Cited by 0
Related Papers
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k